Up 310% the MGC Pharma (ASX:MXC) share price is gaining again today

The MGC Pharma share price is gaining today, up 3% in late morning trade. We take a look at what's moving the shares.

| More on:
medical asx share price represented by doctor giving thumbs up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MGC Pharmaceuticals Ltd (ASX: MXC) share price is gaining today, up 2.5% in late morning trade.

MGC Pharmaceuticals (MGC Pharma) is a biopharma company that produces and develops phytocannabinoid-derived medicines. This morning, it announced an increase in the initial purchase order of one of its patented products.

At the time of writing, the MGC Pharmaceuticals share price has retreated slightly, trading at 8 cents, up 1.25%. 

Let's take a closer look at the announcement and what it means for MGC Pharma shares. 

What did MGC Pharma report?

The MGC Pharma share price is gaining today. In particular, this comes after the company reported an 85% increase in the original purchase order for its medicinal food supplement ArtemiC Rescue from Swiss PharmaCan AG (SPC).

Additionally, shares zoomed 31% higher on 19 February following the initial announcement of the purchase order from SPC. SPC agreed to distribute ArtemiC Rescue worldwide for at least 3 years. The distribution will be focused on countries with high levels of COVID-19.

With the increased order, MGC Pharma reports the deal will result in at least $425,000 of wholesale revenue.

Management commentary

Commenting on the increased order, Roby Zomer, Managing Director of MGC Pharma said:

We are pleased to have extended our agreement with Swiss PharmaCan AG for ArtemiC Rescue. This further agreement will provide more people access to the natural therapeutic benefits of the supplement and ease suffering following the successful Phase II trial results in December.

ArtemiC Rescue is an anti-inflammatory product. It can be taken without any shown drug adverse side effects. Importantly, with direct applications in treating the coronavirus.

According to MGC Pharma, it's been shown to reduce the severity of pain and other symptoms. Particularly, in patients infected with COVID-19. Additionally, it can be used in the community alongside hospital use. The company said it has the "ability to prevent deterioration of COVID-19 patients and achieve faster clinical improvement".

Share price snapshot

Since this time last year, MGC Pharma shares have gained 173%. That compares to an 8% gain on the All Ordinaries Index (ASX: XAO).

Year-to-date the MGC Pharma share price is up 310%.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »